Intelligent Bio Solutions Partners with Syrma Johari for Global Scale

Intelligent Bio Solutions has entered a major global manufacturing partnership with Syrma Johari MedTech Ltd, a move set to sharply reduce costs, improve margins, and speed up its planned US market entry.

Announced today, the agreement strengthens INBS’ manufacturing base as demand for its drug-screening technology grows.

The deal expands Intelligent Bio Solutions’ production capacity for its Intelligent Fingerprinting Drug Screening Reader, with expected annual cost savings of more than 40 percent and a projected 20 percentage point lift in gross margins ahead of a 2026 US launch. The partnership also reduces reliance on a single supplier, improving supply-chain stability across regions.

Also Read: How Emerging Biotech Startups Reshaping the Bioprocessing Future

Syrma Johari’s manufacturing capacity is around four times INBS’ current output, positioning the company to support rising global demand. With more than 45 years of experience, Syrma Johari operates 14 facilities and four design and innovation centers across India, Europe, and the United States. Its vertically integrated model spans electronics, mechanical assembly, PCB manufacturing, functional testing, clean-room processes, and logistics.

Syrma Johari is also preparing to open a new medical-grade plastics manufacturing facility in India in January 2026, further strengthening long-term production capabilities.

The partnership supports Intelligent Bio Solutions’ regulatory and commercial strategy, with Syrma Johari providing quality systems and regulatory documentation across the US, Europe, the UK, Canada, and Asia-Pacific markets.

“Partnering with Syrma Johari is a strategically significant milestone for our business,” said Callistus Sequeira, vice president of global quality and operations at Intelligent Bio Solutions.

 “Partnering with Intelligent Bio Solutions is an exciting opportunity to apply our engineering strength, manufacturing scale, and quality systems to a breakthrough technology with global potential,” said Pankaj Wadke, head international sales & business development at Syrma Johari MedTech Ltd.